Birgitte Brock
Clinical Associate Professor
1 - 1 out of 1Page size: 50
- Published
Glucagon-like peptide-1 (GLP-1) raises blood-brain glucose transfer capacity and hexokinase activity in human brain
Gejl, M., Lerche, S., Egefjord, L., Brock, Birgitte, Møller, N., Vang, K., Rodell, A., Bibby, B. M., Holst, Jens Juul, Rungby, J. & Gjedde, Albert, 2013, In: Frontiers in Neuroenergetics. 5, p. 1-9 10 p., 2.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 40108287
Most downloads
-
248
downloads
Blood-Brain Glucose Transfer in Alzheimer's disease: Effect of GLP-1 Analog Treatment
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
193
downloads
In Alzheimer's disease, 6-month treatment with GLP-1 analog prevents decline of brain glucose metabolism: Randomized, placebo-controlled, double-blind clinical trial
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
132
downloads
Oral administration of sitagliptin activates CREB and is neuroprotective in murine model of brain trauma
Research output: Contribution to journal › Journal article › Research › peer-review
Published